An IDIBAPS team identifies a molecular interaction that drives the aggressiveness of lymphoma and proposes a new therapeutic strategy to combat it.
"La Caixa" Foundation will allocate €150,000 to the project led by Alba Rodríguez, from the IDIBAPS Cellular Immunotherapies for Cancer research gr...
A team led by Joan-Marc Servitja, from the IDIBAPS Pathogenesis and Prevention of Diabetes research group, has demonstrated in mouse models that hi...
A systematic review published in eClinicalMedicine concludes that most antidepressants, when used appropriately, do not significantly increase the...
An international team led by the Clínic-IDIBAPS and the Institute of Cancer Research in London has developed an innovative new method based on DNA...
Ferran Nadeu, a researcher in the IDIBAPS research group Molecular pathology of lymphoid neoplasms located at Esther Koplowitz Centre, has been aw...
A study led by the Clínic-IDIBAPS reveals that the microbiota can predict and enhance patient response to one of the most innovative immunotherapie...
Researchers from the Clinic-IDIBAPS lead an international study, published in The Lancet Respiratory Medicine, which demonstrates the importance of...
An international study led by the Imaging of mood- and anxiety-related disorders research group at IDIBAPS has created a new brain atlas that iden...
